Entyvio
Vedolizumab · Takeda Pharmaceuticals America, Inc.
PRESCRIPTION ONLY (USA)Entyvio ingredients
| Active ingredient | Strength |
|---|---|
| Vedolizumab | 300 mg/5mL, 108 mg/.68mL |
What Entyvio is used for
Entyvio is a specialist medicine (integrin receptor antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Entyvio
- Generic name
- Vedolizumab
- Made by
- Takeda Pharmaceuticals America, Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution, Injection, Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Integrin Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA125476
- On the US market since
- 2014
Official information
- Entyvio prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Vedolizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Entyvio?
Entyvio (Vedolizumab) is a specialist medicine made by Takeda Pharmaceuticals America, Inc., approved by the US FDA.
What are the ingredients of Entyvio?
Entyvio contains Vedolizumab (300 mg/5mL, 108 mg/.68mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA